In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.

The Journal of Antimicrobial Chemotherapy
Jochem B BuilPaul E Verweij

Abstract

The voriconazole and echinocandin combination has been found to be synergistic in vitro and in vivo against most Aspergillus fumigatus isolates, both with a WT azole phenotype and an azole-resistant phenotype. The interaction between isavuconazole and echinocandins is less well studied. This is especially true for azole-resistant isolates. We investigated the in vitro interaction between isavuconazole and anidulafungin for 30 A. fumigatus isolates including 18 azole-resistant isolates with various isavuconazole resistance phenotypes. The isavuconazole/anidulafungin interaction was studied by using an adapted EUCAST-based 2D (12 × 8) chequerboard broth microdilution colorimetric assay using XTT. The interaction was analysed by FIC index (FICi) analysis and Bliss independence (BI) interaction analysis. Both the FICi analysis and the BI analysis showed synergistic interaction between isavuconazole and anidulafungin for the majority of WT and azole-resistant isolates. As we did not see significant beneficial effects of combination therapy in TR46/Y121F/T289A isolates at clinically achievable drug concentrations, it is unlikely that TR46/Y121F/T289A infections would benefit from isavuconazole and anidulafungin combination therapy. I...Continue Reading

References

Aug 30, 2001·Journal of Clinical Microbiology·J MeletiadisUNKNOWN EUROFUNG Network
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·William R KirkpatrickThomas F Patterson
Sep 18, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P H ChandrasekarE K Manavathu
Dec 6, 2006·Antimicrobial Agents and Chemotherapy·Charalampos AntachopoulosThomas J Walsh
Oct 3, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing
Oct 21, 2009·The Journal of Antimicrobial Chemotherapy·C ViscoliUNKNOWN Infectious Disease Group of the EORTC
May 23, 2012·Diagnostic Microbiology and Infectious Disease·Suganthini Krishnan-NatesanPranatharthi H Chandrasekar
Nov 7, 2012·The Journal of Antimicrobial Chemotherapy·Seyedmojtaba SeyedmousaviJohan W Mouton
Nov 28, 2012·Antimicrobial Agents and Chemotherapy·Seyedmojtaba SeyedmousaviPaul E Verweij
Aug 20, 2014·Antimicrobial Agents and Chemotherapy·Aspasia KatragkouThomas J Walsh
Jan 20, 2015·Annals of Internal Medicine·Kieren A MarrJohan A Maertens
Aug 19, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Paul E VerweijJ Peter Donnelly
Jul 2, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonJohn E Bennett
Jan 27, 2018·Journal of Fungi·Felix BongominDavid W Denning
Mar 17, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A J UllmannO A Cornely

❮ Previous
Next ❯

Citations

Jul 24, 2021·Revista iberoamericana de micología·Inmaculada Quiles-Melero, Julio García-Rodríguez

❮ Previous
Next ❯

Software Mentioned

JAC
GraphPad Prism
Excel

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.